Benjamin L. Ebert, President and CEO at Dana-Farber Cancer Institute, shared Beth Israel Lahey Health‘s post on LinkedIn:
“Congratulations to Peter Shorett on being named the next President and CEO of Beth Israel Lahey Health.
Through our work together, I’ve come to know Peter as an exceptional leader and trusted partner. He brings a rare combination of intellect, humility, steadiness, and an unwavering commitment to doing what is best for patients and families.
As Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center continue to strengthen our collaboration in cancer care, I’ve seen firsthand Peter’s ability to build strong relationships, foster alignment, and move important work forward with purpose and integrity. He understands that excellent healthcare depends not only on strategy and execution, but also on trust, shared values, and a deep sense of mission.
Peter’s appointment is great news for BILH and for the many communities it serves. I look forward to continuing our work together in the years ahead.
Congratulations again, Peter!”
Quoting Beth Israel Lahey Health:
“Today, we are proud to announce that Peter Shorett has been named the next President and CEO of Beth Israel Lahey Health, effective January 2027.
A founding executive of BILH, Peter has helped shape our organization from the beginning and has been instrumental in advancing our purpose, growth, and strategic vision.
As Peter shared, ‘The opportunity to lead the organization that I know and love – and that I helped bring into being – is one of the greatest privileges of my life.’
Please join us in congratulating Peter as we begin this exciting new chapter for BILH.
Other articles about Dana-Farber on OncoDaily.